Latham BioPharm Group, part of Sia Partners

Latham BioPharm Group (LBG), part of Sia Partners, is a leading life sciences consulting company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies to solve complex business, regulatory, and product development challenges. Our experienced consultants come from large pharmaceutical companies, small biotechs, academia, and global CROs/CDMOs, and many have even held senior positions with government agencies. Since our founding in 1996, we have grown steadily and have built a robust capability set that has enabled us to help life sciences companies of various sizes drive long-term value into their organizations. In 2022, we became part of Sia...

Biodefense and pandemic response,strategic consulting,biopharmaceutical product development services,government/non-dilutive funding services,medical device and diagnostics consulting,cell and gene therapy consulting,early discovery services,animal health product development consulting,market research services,program/project management services,government contract management,government proposal development,and due diligence/m&a support

Latham biopharm group, part of sia partners operates in the Business consulting and services industry.

Latham biopharm group, part of sia partners's revenue is 11m - 100m

Latham biopharm group, part of sia partners has 51 - 200 employees.